Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.

Davis KL, Gray ES, Moore PL, Decker JM, Salomon A, Montefiori DC, Graham BS, Keefer MC, Pinter A, Morris L, Hahn BH, Shaw GM.

Virology. 2009 May 10;387(2):414-26. doi: 10.1016/j.virol.2009.02.022. Epub 2009 Mar 18.

PMID:
19298995
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antigenic and immunogenic sites of HIV-2 glycoproteins.

Chiodi F, Björling E, Samuelsson A, Norrby E.

Chem Immunol. 1993;56:61-77. Review.

PMID:
8452654
[PubMed - indexed for MEDLINE]
3.

Specificity of the autologous neutralizing antibody response.

Moore PL, Gray ES, Morris L.

Curr Opin HIV AIDS. 2009 Sep;4(5):358-63. doi: 10.1097/COH.0b013e32832ea7e8. Review.

PMID:
20048698
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design.

Bonsignori M, Alam SM, Liao HX, Verkoczy L, Tomaras GD, Haynes BF, Moody MA.

Trends Microbiol. 2012 Nov;20(11):532-9. doi: 10.1016/j.tim.2012.08.011. Epub 2012 Sep 13. Review.

PMID:
22981828
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

Benjelloun F, Lawrence P, Verrier B, Genin C, Paul S.

J Virol. 2012 Dec;86(24):13152-63. doi: 10.1128/JVI.01110-12. Epub 2012 Sep 26. Review.

PMID:
23015715
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The Antibody Response against HIV-1.

Overbaugh J, Morris L.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039. doi: 10.1101/cshperspect.a007039. Review.

PMID:
22315717
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Carbohydrate targets in HIV vaccine research: lessons from failures.

Pashov A, Garimalla S, Monzavi-Karbassi B, Kieber-Emmons T.

Immunotherapy. 2009 Sep;1(5):777-94. doi: 10.2217/imt.09.44. Review.

PMID:
20636023
[PubMed - indexed for MEDLINE]
8.

Clade specific neutralising vaccines for HIV: an appropriate target?

McKnight A, Aasa-Chapman MM.

Curr HIV Res. 2007 Nov;5(6):554-60. Review.

PMID:
18045111
[PubMed - indexed for MEDLINE]
9.

Protective immunity against HIV infection: lessons from HIV-2 infection.

Rowland-Jones S.

Future Microbiol. 2006 Dec;1(4):427-33. Review.

PMID:
17661633
[PubMed - indexed for MEDLINE]
10.

Multiantibody strategies for HIV.

Hiatt A, Zeitlin L, Whaley KJ.

Clin Dev Immunol. 2013;2013:632893. doi: 10.1155/2013/632893. Epub 2013 Jun 6. Review.

PMID:
23840243
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Catalytic antibodies to HIV: physiological role and potential clinical utility.

Planque S, Nishiyama Y, Taguchi H, Salas M, Hanson C, Paul S.

Autoimmun Rev. 2008 Jun;7(6):473-9. doi: 10.1016/j.autrev.2008.04.002. Epub 2008 Apr 29. Review.

PMID:
18558365
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

HIV-1-specific antibody responses during acute and chronic HIV-1 infection.

Tomaras GD, Haynes BF.

Curr Opin HIV AIDS. 2009 Sep;4(5):373-9. doi: 10.1097/COH.0b013e32832f00c0. Review.

PMID:
20048700
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

HIV-2: the forgotten AIDS virus.

de Silva TI, Cotten M, Rowland-Jones SL.

Trends Microbiol. 2008 Dec;16(12):588-95. doi: 10.1016/j.tim.2008.09.003. Epub 2008 Oct 27. Review.

PMID:
18964021
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk